Results 131 to 140 of about 118,394 (314)

Antioxidants and Antidiabetic Potential of Polyphenolic Fractions and Crude Extracts of Rhus typhina Fruit, Punica granatum L. Peel, and Terminalia catappa L. Leaves: In Vitro and In Vivo Evaluation

Chemistry &Biodiversity, EarlyView.
This graphical abstract represents the extraction, characterization, and biological evaluation of bioactive compounds derived from specific plant sources. The top section illustrates Rhus coriaria (sumac) fruit, Punica granatum (pomegranate) peel and Terminalia catappa (Indian almond) leaves', which are known for their rich phytochemical composition ...
Mudassir Nazir, Muhammad Abdul Haq, Syed Arsalan Ali, Syed Muhammad Ghufran Saeed, Muhammad Ali Ajmal, Muhammad Nisar, Taseer Ahmed Khan, Alexandros Tsoupras, Shahina Naz   +8 more
wiley   +1 more source

ORAL MANIFESTATION OF RENAL OSTHEODISTROPHY IN CHILDREN

Romanian Journal of Oral Rehabilitation, 2018
Very rare in children, the brown tumor, or osteoclastoma, is an understudied ectopic entity that causes severe debilitation in patients with chronic renal insufficiency.
Iuliana Magdalena Stârcea, Anca Ivanov, Adriana Mocanu, Vasile Valeriu Lupu, Mirabela Subotnicu, Mihaela Munteanu, Ancuţa Ignat, Ingrith Miron   +7 more
doaj  

Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study. [PDF]

Ann Intern Med, 2023
Muiru AN, Hsu JY, Zhang X, Appel LJ, Chen J, Cohen DL, Drawz PE, Freedman BI, Go AS, He J, Horwitz EJ, Hsu RK, Lash JP, Liu KD, McCoy IE, Porter A, Rao P, Ricardo AC, Rincon-Choles H, Sondheimer J, Taliercio J, Unruh M, Hsu CY, CRIC Study Investigators.   +23 more
europepmc   +1 more source

Deep Learning-Based Quantitative Assessment of Renal Chronicity Indices in Lupus Nephritis [PDF]

arXiv
Background: Renal chronicity indices (CI) have been identified as strong predictors of long-term outcomes in lupus nephritis (LN) patients. However, assessment by pathologists is hindered by challenges such as substantial time requirements, high interobserver variation, and susceptibility to fatigue.
arxiv  

HEMOFILTRATION — A NEW METHOD FOR THE TREATMENT OF CHRONIC RENAL INSUFFICIENCY

, 1977
E. Quellhorst, B Schuenemann, B. Doht
openalex   +1 more source

Natural History of Renal Function in Childhood Chronic Renal Insufficiency (CRI) [PDF]

, 1999
Gian Luigi Ardissino, Valeria Daccò, Sara Testa, Aldo Claris Appiani, F Sereni   +4 more
openalex   +1 more source

Steerable Delivery Sheath for Optimized LAA Closure: First Experience and Procedural Outcomes

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The new Amplatzer Steerable Delivery Sheath is a delivery system designed to improve ease‐of‐use and procedural results of left atrial appendage closure (LAAC). We aimed to compare procedural results after switching our LAAC program at a tertiary care center with the Amulet device to the Steerable Delivery Sheath, with a control ...
Matthias Mezger, Christina Paitazoglou, Christian Frerker, Thomas Stiermaier, Ingo Eitel   +4 more
wiley   +1 more source

Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study. [PDF]

JCI Insight, 2022
Wen D, Zheng Z, Surapaneni A, Yu B, Zhou L, Zhou W, Xie D, Shou H, Avila-Pacheco J, Kalim S, He J, Hsu CY, Parsa A, Rao P, Sondheimer J, Townsend R, Waikar SS, Rebholz CM, Denburg MR, Kimmel PL, Vasan RS, Clish CB, Coresh J, Feldman HI, Grams ME, Rhee EP, CKD Biomarkers Consortium and CRIC Study Investigators.   +26 more
europepmc   +1 more source

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu, Ziqing Wang, Dan Chen, Haojie Zhang, Junhua Ge, Jian Li   +5 more
wiley   +1 more source

Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289‐1292 doi:10.1002/bcp.70044

British Journal of Clinical Pharmacology, EarlyView.
Carmelo Rizzari, Stefan Schwartz
wiley   +1 more source